Literature DB >> 20827105

Impact of traditional hospital strain of methicillin-resistant Staphylococcus aureus (MRSA) and community strain of MRSA on mortality in patients with community-onset S aureus bacteremia.

Shey-Ying Chen1, Jann-Tay Wang, Tony Hsiu-Hsi Chen, Mei-Shu Lai, Wei-Chu Chie, Kuo-Liong Chien, Po-Ren Hsueh, Jiun-Ling Wang, Shan-Chwen Chang.   

Abstract

Community-associated methicillin-resistant Staphylococcus aureus (MRSA) has become an important pathogen in community and nosocomial infections. The impact of these emerging MRSA strains on mortality in adult patients with community-onset S aureus bacteremia remains uncertain. We defined community strain MRSA (CoSt-MRSA) and hospital strain MRSA (HoSt-MRSA) according to the results of staphylococcus cassette chromosome mec (SCCmec) molecular typing: CoSt-MRSA isolates had SCCmec type IV or V genes, and HoSt-MRSA isolates had SCCmec type I, II, or III genes. We quantitatively evaluated the impact of the MRSA strain on mortality in patients with CoSt-MRSA or HoSt-MRSA bacteremia by comparison with mortality in patients with methicillin-susceptible S aureus (MSSA) bacteremia.We studied an observational cohort of 500 patients with MSSA bacteremia, 111 patients with CoSt-MRSA, and 133 patients with HoSt-MRSA bacteremia from January 1, 2001, through December 31, 2007. The 90-day cumulative probability of survival in patients with MSSA, CoSt-MRSA, and HoSt-MRSA bacteremia was 71%, 70%, and 55%, respectively (p = 0.014, by Wilcoxon rank-sum test).Compared to patients with MSSA bacteremia, patients with HoSt-MRSA bacteremia were associated with an increased risk of mortality in the first multivariate analysis model adjusting for all potential confounders (hazard ratio [HR], 1.525; 95% confidence interval [CI], 1.091-2.131), in the second model adjusting for all confounders except acute severity of bacteremia (HR, 1.489; 95% CI, 1.071-2.070), and in stratified analysis in patients with low Charlson comorbidity scores (score 0-2) (HR, 3.093; 95% CI, 1.507-6.350).Compared to patients with MSSA bacteremia, patients with CoSt-MRSA bacteremia did not show significant differences in mortality rate in the 2 multivariate analysis models (first model: HR, 1.106; 95% CI, 0.748-1.637; second model: HR, 1.028; 95% CI, 0.697-1.516) or in stratified analysis (HR, 1.092; 95% CI, 0.539-2.214).In conclusion, using MSSA as reference, traditional hospital strain MRSA had a higher impact on bacteremia mortality than community strain MRSA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20827105     DOI: 10.1097/MD.0b013e3181f1851e

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  12 in total

1.  agr dysfunction affects staphylococcal cassette chromosome mec type-dependent clinical outcomes in methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  Chang Kyung Kang; Jeong Eun Cho; Yoon Jeong Choi; Younghee Jung; Nak-Hyun Kim; Chung-Jong Kim; Taek Soo Kim; Kyoung-Ho Song; Pyoeng Gyun Choe; Wan Beom Park; Ji-Hwan Bang; Eu Suk Kim; Kyoung Un Park; Sang Won Park; Nam-Joong Kim; Myoung-Don Oh; Hong Bin Kim
Journal:  Antimicrob Agents Chemother       Date:  2015-03-16       Impact factor: 5.191

2.  MRSA Septicemia With Septic Arthritis and Prostatic, Intraretinal, Periapical, and Lung Abscesses.

Authors:  Ryan A Denu; Deval Patel; Benjamin J Becker; Thomas Shiffler; Peter Kleinschmidt
Journal:  WMJ       Date:  2020-03

3.  Predicting methicillin resistance among community-onset Staphylococcus aureus bacteremia patients with prior healthcare-associated exposure.

Authors:  S-Y Chen; W-C Chiang; M H-M Ma; P-R Hsueh; S-C Chang; C-C Fang; S-C Chen; W-J Chen; W-C Chie; M-S Lai
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-05-19       Impact factor: 3.267

Review 4.  Predictors of mortality in Staphylococcus aureus Bacteremia.

Authors:  Sebastian J van Hal; Slade O Jensen; Vikram L Vaska; Björn A Espedido; David L Paterson; Iain B Gosbell
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

5.  The effect of staphylococcal cassette chromosome mec (SCCmec) type on clinical outcomes in methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  Jennifer H Han; Paul H Edelstein; Warren B Bilker; Ebbing Lautenbach
Journal:  J Infect       Date:  2012-09-06       Impact factor: 6.072

6.  Community-associated methicillin-resistant Staphylococcus aureus bacteremia and endocarditis among HIV patients: a cohort study.

Authors:  Jon P Furuno; Jennifer K Johnson; Marin L Schweizer; Anayochukwu Uche; Oscar C Stine; Simone M Shurland; Graeme N Forrest
Journal:  BMC Infect Dis       Date:  2011-10-31       Impact factor: 3.090

7.  Comparison of Outcomes among Adult Patients with Nosocomial Bacteremia Caused by Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus: A Retrospective Cohort Study.

Authors:  Jann-Tay Wang; Le-Yin Hsu; Tsai-Ling Lauderdale; Wen-Chien Fan; Fu-Der Wang
Journal:  PLoS One       Date:  2015-12-21       Impact factor: 3.240

8.  Impact of prior healthcare-associated exposure on clinical and molecular characterization of methicillin-susceptible Staphylococcus aureus bacteremia: results from a retrospective cohort study.

Authors:  Pao-Yu Chen; Yu-Chung Chuang; Jann-Tay Wang; Shan-Chwen Chang
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

9.  Difference in agr dysfunction and reduced vancomycin susceptibility between MRSA bacteremia involving SCCmec types IV/IVa and I-III.

Authors:  Hee-Chang Jang; Seung-Ji Kang; Su-Mi Choi; Kyung-Hwa Park; Jong-Hee Shin; Hyon E Choy; Sook-In Jung; Hong Bin Kim
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

10.  Community-onset Staphylococcus aureus infections presenting to general practices in South-eastern Australia.

Authors:  C M Bennett; G W Coombs; G M Wood; B P Howden; L E A Johnson; D White; P D R Johnson
Journal:  Epidemiol Infect       Date:  2013-07-18       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.